Literature DB >> 11463336

Molecular modelling and experimental studies of mutation and cell-adhesion sites in the fibronectin type III and whey acidic protein domains of human anosmin-1.

A Robertson1, G S MacColl, J A Nash, M K Boehm, S J Perkins, P M Bouloux.   

Abstract

Anosmin-1, the gene product of the KAL gene, is implicated in the pathogenesis of X-linked Kallmann's syndrome. Anosmin-1 protein expression is restricted to the basement membrane and interstitial matrix of tissues affected in this syndrome during development. The anosmin-1 sequence indicates an N-terminal cysteine-rich domain, a whey acidic protein (WAP) domain, four fibronectin type III (FnIII) domains and a C-terminal histidine-rich region, and shows similarity with cell-adhesion molecules, such as neural cell-adhesion molecule, TAG-1 and L1. We investigated the structural and functional significance of three loss-of-function missense mutations of anosmin-1 using comparative modelling of the four FnIII and the WAP domains based on known NMR and crystal structures. Three missense mutation-encoded amino acid substitutions, N267K, E514K and F517L, were mapped to structurally defined positions on the GFCC' beta-sheet face of the first and third FnIII domains. Electrostatic maps demonstrated large basic surfaces containing clusters of conserved predicted heparan sulphate-binding residues adjacent to these mutation sites. To examine these modelling results anosmin-1 was expressed in insect cells. The incorporation of the three mutations into recombinant anosmin-1 had no effect on its secretion. The removal of two dibasic motifs that may constitute potential physiological cleavage sites for anosmin-1 had no effect on cleavage. Peptides based on the anosmin-1 sequences R254--K285 and P504--K527 were then synthesized in order to assess the effect of the three mutations on cellular adhesion, using cell lines that represented potential functional targets of anosmin-1. Peptides (10 microg/ml) incorporating the N267K and E514K substitutions promoted enhanced adhesion to 13.S.1.24 rat olfactory epithelial cells and canine MDCK1 kidney epithelial cells (P<0.01) compared with the wild-type peptides. This result was attributed to the introduction of a lysine residue adjacent to the large basic surfaces. We predict that two of the three missense mutants increase the binding of anosmin-1 to an extracellular target, possibly by enhancing heparan sulphate binding, and that this critically affects the function of anosmin-1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11463336      PMCID: PMC1221995          DOI: 10.1042/0264-6021:3570647

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  59 in total

1.  IFN-gamma and transforming growth factor-beta 1 differently regulate fibronectin and laminin receptors of human differentiating monocytic cells.

Authors:  B Bauvois; D Rouillard; J Sanceau; J Wietzerbin
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

2.  Transformed Lepidopteran insect cells: new sources of recombinant human tissue plasminogen activator.

Authors:  P J Farrell; L A Behie; K Iatrou
Journal:  Biotechnol Bioeng       Date:  1999-08-20       Impact factor: 4.530

3.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

Authors:  A M de Vos; M Ultsch; A A Kossiakoff
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

4.  Comparative analysis of structurally defined heparin binding sequences reveals a distinct spatial distribution of basic residues.

Authors:  H Margalit; N Fischer; S A Ben-Sasson
Journal:  J Biol Chem       Date:  1993-09-15       Impact factor: 5.157

5.  Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein.

Authors:  D J Leahy; W A Hendrickson; I Aukhil; H P Erickson
Journal:  Science       Date:  1992-11-06       Impact factor: 47.728

6.  Structure of the X-linked Kallmann syndrome gene and its homologous pseudogene on the Y chromosome.

Authors:  I del Castillo; M Cohen-Salmon; S Blanchard; G Lutfalla; C Petit
Journal:  Nat Genet       Date:  1992-12       Impact factor: 38.330

7.  X chromosome-linked Kallmann syndrome: stop mutations validate the candidate gene.

Authors:  J P Hardelin; J Levilliers; I del Castillo; M Cohen-Salmon; R Legouis; S Blanchard; S Compain; P Bouloux; J Kirk; C Moraine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 8.  X-linked Kallmann syndrome. A neuronal targeting defect in the olfactory system?

Authors:  B Lutz; E I Rugarli; G Eichele; A Ballabio
Journal:  FEBS Lett       Date:  1993-06-28       Impact factor: 4.124

9.  Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome.

Authors:  J P Hardelin; J Levilliers; S Blanchard; J C Carel; M Leutenegger; J P Pinard-Bertelletto; P Bouloux; C Petit
Journal:  Hum Mol Genet       Date:  1993-04       Impact factor: 6.150

10.  Expression of the receptor-linked protein tyrosine phosphatase LAR: proteolytic cleavage and shedding of the CAM-like extracellular region.

Authors:  M Streuli; N X Krueger; P D Ariniello; M Tang; J M Munro; W A Blattler; D A Adler; C M Disteche; H Saito
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more
  10 in total

1.  Identification of two novel missense mutations in the KAL1 gene in Han Chinese subjects with Kallmann Syndrome.

Authors:  T-S Jap; C-Y Chiu; J-F Lirng; G-S Won
Journal:  J Endocrinol Invest       Date:  2010-06-04       Impact factor: 4.256

Review 2.  The comparative biology of whey proteins.

Authors:  Kaylene J Simpson; Kevin R Nicholas
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-07       Impact factor: 2.673

3.  Cell adhesion to anosmin via α5β1, α4β1, and α9β1 integrins.

Authors:  Yukinori Endo; Hiroko Ishiwata-Endo; Kenneth M Yamada
Journal:  Cell Adh Migr       Date:  2018-02-20       Impact factor: 3.405

Review 4.  Human genetic disorders of axon guidance.

Authors:  Elizabeth C Engle
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03       Impact factor: 10.005

5.  Cross-talk of anosmin-1, the protein implicated in X-linked Kallmann's syndrome, with heparan sulphate and urokinase-type plasminogen activator.

Authors:  Youli Hu; David González-Martínez; Soo-Hyun Kim; Pierre Marc Gilles Bouloux
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

6.  Identification of gene transcripts expressed by postsynaptic neurons during synapse formation encoding cell surface proteins with presumptive synaptogenic activity.

Authors:  Juan L Brusés
Journal:  Synapse       Date:  2010-01       Impact factor: 2.562

7.  Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.

Authors:  Catherine Dodé; Luis Teixeira; Jacqueline Levilliers; Corinne Fouveaut; Philippe Bouchard; Marie-Laure Kottler; James Lespinasse; Anne Lienhardt-Roussie; Michèle Mathieu; Alexandre Moerman; Graeme Morgan; Arnaud Murat; Jean-Edmont Toublanc; Slawomir Wolczynski; Marc Delpech; Christine Petit; Jacques Young; Jean-Pierre Hardelin
Journal:  PLoS Genet       Date:  2006-09-01       Impact factor: 5.917

8.  Novel application of luciferase assay for the in vitro functional assessment of KAL1 variants in three females with septo-optic dysplasia (SOD).

Authors:  Mark J McCabe; Youli Hu; Louise C Gregory; Carles Gaston-Massuet; Kyriaki S Alatzoglou; José W Saldanha; Angelica Gualtieri; Ajay Thankamony; Ieuan Hughes; Sharron Townshend; Juan-Pedro Martinez-Barbera; Pierre-Marc Bouloux; Mehul T Dattani
Journal:  Mol Cell Endocrinol       Date:  2015-09-14       Impact factor: 4.102

9.  Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1.

Authors:  Youli Hu; Scott E Guimond; Paul Travers; Steven Cadman; Erhard Hohenester; Jeremy E Turnbull; Soo-Hyun Kim; Pierre-Marc Bouloux
Journal:  J Biol Chem       Date:  2009-08-20       Impact factor: 5.157

10.  Anosmin-1 modulates fibroblast growth factor receptor 1 signaling in human gonadotropin-releasing hormone olfactory neuroblasts through a heparan sulfate-dependent mechanism.

Authors:  David González-Martínez; Soo-Hyun Kim; Youli Hu; Scott Guimond; Jonathan Schofield; Paul Winyard; Gabriella Barbara Vannelli; Jeremy Turnbull; Pierre-Marc Bouloux
Journal:  J Neurosci       Date:  2004-11-17       Impact factor: 6.167

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.